Quarterly report pursuant to Section 13 or 15(d)

Marketable Equity Securities - Schedule of Investments in Marketable Equity Securities (Details)

v3.19.1
Marketable Equity Securities - Schedule of Investments in Marketable Equity Securities (Details) - USD ($)
Mar. 31, 2019
Dec. 31, 2018
Schedule Of Available For Sale Securities [Line Items]    
Cost Basis $ 755,487  
Gross Unrealized Gains 966,569  
Value 1,722,056 $ 1,567,607
Common stocks    
Schedule Of Available For Sale Securities [Line Items]    
Cost Basis 755,487  
Gross Unrealized Gains 966,569  
Value $ 1,722,056